| Literature DB >> 34681809 |
Radek Procházka1, Alexandra Bartková1,2, Lucie Němcová1, Matej Murín1, Ahmed Gad1,3, Kateřina Marcollová1, Veronika Kinterová1, Andrea Lucas-Hahn4, Jozef Laurinčík1,2.
Abstract
The developmental potential of porcine oocytes cultured in vitro was remarkably enhanced in a medium containing FGF2, LIF and IGF1 (FLI) when compared to a medium supplemented with gonadotropins and EGF (control). We analyzed the molecular background of the enhanced oocyte quality by comparing the time course of MAPK3/1 and AKT activation, and the expression of genes controlled by these kinases in cumulus-oocyte complexes (COCs) cultured in FLI and the control medium. The pattern of MAPK3/1 activation in COCs was very similar in both media, except for a robust increase in MAPK3/1 phosphorylation during the first hour of culture in the FLI medium. The COCs cultured in the FLI medium exhibited significantly higher activity of AKT than in the control medium from the beginning up to 16 h of culture; afterwards a deregulation of AKT activity occurred in the FLI medium, which was not observed in the control medium. The expression of cumulus cell genes controlled by both kinases was also modulated in the FLI medium, and in particular the genes related to cumulus-expansion, signaling, apoptosis, antioxidants, cell-to-cell communication, proliferation, and translation were significantly overexpressed. Collectively, these data indicate that both MAPK3/1 and AKT are implicated in the enhanced quality of oocytes cultured in FLI medium.Entities:
Keywords: AKT kinase; FGF2; IGF1; LIF; MAP kinase 3/1; gene expression; oocyte competence; oocyte maturation
Mesh:
Substances:
Year: 2021 PMID: 34681809 PMCID: PMC8537457 DOI: 10.3390/ijms222011148
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Effect of gonadotropins, EGF and FLI cytokines on maturation of porcine oocytes in vitro.
| Type of | No. of Oocytes | % of Oocytes in | ||
|---|---|---|---|---|
| Medium | Examined | GV | GVBD | MII |
| M199+BSA | 154 | 63.65 ± 5.75 A | 9.18 ± 0.94 AB | 26.95 ± 5.79 A |
| +PMSG+hCG | 150 | 63.58 ± 6.93 A | 10.38 ± 3.55 AB | 26.08 ± 5.03 A |
| +PMSG+hCG+EGF | 146 | 13.63 ± 6.45 B | 16.53 ± 2.38 A | 69.90 ± 4.05 B |
| FLI | 163 | 1.20 ± 0.69 B | 1.3 ± 0.76 B | 97.5 ± 0.14 C |
Data are expressed in percentages ± SEM. Values with different superscripts or no common letter in the superscript within a column are significantly different. GV: germinal vesicle; GVBD: germinal vesicle breakdown; MII: metaphase II.
Effect of FGF2, LIF and IGF1 on maturation of porcine oocytes in vitro.
| Type of | No. of Oocytes | % of Oocytes in | ||
|---|---|---|---|---|
| Medium | Examined | GV | GVBD | MII |
| Control | 91 | 22.11 ± 4.86 A | 12.41 ± 3.16 | 65.48 ± 3.12 A |
| +FGF2 | 97 | 0 ± 0 B | 8.03 ± 2.93 | 91.97 ± 2.94 B |
| +IGF1 | 97 | 4.80 ± 2.64 B | 4.13 ± 2.29 | 91.07 ± 4.47 B |
| +LIF | 92 | 0 ± 0 B | 4.67 ± 2.65 | 95.33 ± 2.45 B |
| FLI | 87 | 0 ± 0 B | 3.57 ± 0.50 | 96.43 ± 0.50 B |
Control: M199 supplemented with PMSG, hCG and EGF. FLI: Control medium supplemented with FGF2, LIF and IGF1. GV: germinal vesicle; GVBD: germinal vesicle breakdown; MII: metaphase II. Data are expressed in percentages ± SEM. Values with different superscripts within the column are significantly different (P < 0.01 for GV values; P < 0.001 for MII values).
Effect of FLI medium on the course of maturation of porcine oocytes in vitro.
| Type of | Time of | No. of Oocytes | % of Oocytes in | ||
|---|---|---|---|---|---|
| Medium | Culture (h) | Examined | GV | GVBD | MII |
| Control | 16 | 86 | 86.63 ± 5.95 A | 13.38 ± 5.95 A | 0 ± 0 A |
| FLI | 16 | 81 | 81.48 ± 6.25 A | 18.53 ± 6.25 A | 0 ± 0 A |
| Control | 24 | 97 | 71.93 ± 6.76 A | 22.40 ± 4.44 A | 5.68 ± 2.44 A |
| FLI | 24 | 99 | 30.83 ± 6.10 B | 56.03 ± 2.53 B | 13.15 ± 5.74 A |
| Control | 44 | 89 | 13.40 ± 6.61 A | 18.55 ± 7.45 A | 68.05 ± 5.72 A |
| FLI | 44 | 92 | 0 ± 0 A | 4.63 ± 2.67 A | 95.38 ± 2.67 B |
Data are expressed in percentages ± SEM. Values with different superscripts within the same interval of culture are significantly different (P < 0.05 for GV and MII values; P < 0.001 for GVBD value). GV: germinal vesicle; GVBD: germinal vesicle breakdown; MII: metaphase II.
Development of porcine oocytes cultured in control and FLI medium after parthenogenetic activation.
| Type of Medium | No. of Activated | Cleavage Rate | Blastocyst Rate |
|---|---|---|---|
| Control | 95 | 70.51 ± 1.39 A | 20.69 ± 3.45 A |
| FLI | 100 | 87.88 ± 1.99 B | 34.07 ± 0.38 B |
Data are expressed in percentages ± SEM. Values with different superscripts within the column are significantly different (P < 0.01 for cleavage rate; P < 0.05 for blastocyst rate).
Figure 1Time course of MAPK3/1 activation in COCs cultured in control and FLI medium. Activation of MAPK3/1 in control and FLI medium during short-term (A) or long-term (C) culture. The panels show representative results of immunoblotting of phosphorylated and total MAPK3/1 in samples of 25 COCs cultured in vitro for the indicated periods of time. Denuded oocytes (DO) originating from COCs cultured for 4 h or 40 h were used for assessing their contribution to the entire COCs signal. Quantification of the activated MAPK3/1 in three independent experiments was performed by densitometry and is shown in the graphs as proportions of phosphorylated and total MAPK3/1, and expressed in arbitrary units as the fold increase over the proportion found in unstimulated COCs at the beginning of culture (B,D). The different superscripts or superscripts with no common letter above the columns indicate significant differences within the same treatment. Asterisks above the columns indicate a significant difference between the treatments at the same time of culture (p < 0.05).
Figure 2Time course of AKT activation in COCs culture in control and FLI medium. Activation of AKT in control and FLI medium during short-term (A) or long-term (C) culture. The panels show representative results of immunoblotting of phosphorylated and total AKT in samples of 25 COCs cultured in vitro for the indicated periods of time. Denuded oocytes (DO) cultured for 4 or 40 h were used for assessing their contribution to the entire COC signal. Quantification of the activated AKT in three independent experiments was performed by densitometry and is shown in the graphs as proportions of phosphorylated and total AKT, and expressed in arbitrary units as the fold increase over the proportion found in unstimulated COCs at the beginning of the culture (B,D). The different superscripts or superscripts with no common letter above the columns indicate significant differences within the same treatment. The asterisks above the columns indicate a significant difference between the treatments at the same time of culture (p < 0.05).
Figure 3Gene expression in cumulus cells (CCs) cultured in control and FLI medium. Cumulus expansion-related genes (A), signaling pathways-related genes (B), genes related to apoptosis and antioxidants (C), and others (D). Differences are expressed in arbitrary units as the fold increase over the proportion found in CCs cultured in control (C). Asterisks above the columns indicate significant differences between the treatments at the same time of culture (p < 0.05 for single asterisk; p < 0.01 for double asterisk, p < 0.001 for triple asterisk).
The composition of the control and FLI medium.
| Component | Supplier | Control Medium | FLI Medium |
|---|---|---|---|
| TCM199 | Sigma, M7528 | TCM199 | TCM199 |
| Sodium pyruvate | Sigma, P4562 | 0.2 mM | 0.2 mM |
| L-glutamin | Sigma, G8540 | 6.85 mM | 6.85 mM |
| Cysteine | Sigma, C7352 | 0.57 mM | 0.57 mM |
| Gentamycin | Roth, 0233 | 50 µg/mL | 50 µg/mL |
| BSA | Sigma, A7030 | 1 mg/mL | 1 mg/mL |
| PMSG | Prospec 1, HOR-272 | 10 IU/mL | 10 IU/mL |
| hCG | Prospec 1, HOR-250 | 10 IU/mL | 10 IU/mL |
| EGF | PeproTech 2, AF-100-15 | 10 ng/mL | 10 IU/mL |
| human LIF | Merck 3, LIF1005 | − | 2 µL/mlL |
| human IGF1 | PeproTech 2, AF-100-11 | − | 20 ng/mL |
| human FGF2 | Sigma, F0291 | − | 40 ng/mL |
1 Prospec, Rehovot, Israel; 2 PeproTech, London, England; 3 Merck Life Science, Prague, Czech Republic.
List of primers used for RT-qPCR.
| Gene | Amplicon Length | Sequence 5´–3´ | Gene Accession No. | Tan |
|---|---|---|---|---|
|
| 157 | TAC TCC TTC CAG ACC CAC GA | NM_001159776.1 | 53 |
|
| 141 | AAT TCC TAT GCT CGT AAT | NC_000845 | 57 |
|
| 251 | AAG CGC ATT GGA GAT GAA CT | XM_003127290.5 | 55 |
|
| 196 | GAA ACC CCT AGT GCC ATC AA | XM_021077292.1 | 55 |
|
| 128 | CAA GAT TCT CCT GTG CTA | NM_214301.2 | 56 |
|
| 116 | CAG TGC TCC TAC TTC AAG | NM_214088.1 | 58 |
|
| 218 | GAG GCG GCC CTG AAC ATA | XM_013994425.2 | 58 |
|
| 140 | AAG ACT GAT GCA CCG GAC AG | NM_214316.1 | 53 |
|
| 148 | GAATCTAATCAGGAGGTT | XM_003129314.3 | 53 |
|
| 241 | CCC TCA AGG AGA TCA GCG AC | NM_214007 | 53 |
|
| 129 | ATG GCT ACT GTT TGC ACG GA | XM_013978775.2 | 58 |
|
| 149 | ATG GAG ACA CTT TGG ATT | NM_214014.3 | 53 |
|
| 113 | ATT ATC CGT AGC GAA CTC AT | NM_001135959.1 | 57 |
|
| 227 | AGT GAT CCT TAC CAC GCC AC | NM_001244212.1 | 57 |
|
| 127 | GGT CTC CAG TGT GTC GCA AT | NM_214201.1 | 56 |
|
| 407 | GAA GTC ATG GGC AGG GAC AAT TC | NM_214053.1 | 54 |
|
| 195 | GAC CGT CAC CTG CTT TGA GA | NM_214114.1 | 54 |
|
| 157 | TAA GGT GCC ATG GAA CAG GC | NM_001198922.1 | 55 |
|
| 151 | CGA TGG CCA GGG ATC TCT TC | XM_003127584.6 | 53 |
|
| 159 | CGC GCA GGA AAT CTC AAT CG | XM_003482597.4 | 57 |
|
| 153 | TAA TGC AGA CAC CTT GGC ACT | NM_001291925.1 | 55 |
|
| 152 | ACT GGC TGG ACA TCA GCA GT | XM_001927064.5 | 55 |
|
| 208 | CGC CAA TAC TGT GAT TTC C |
| 54 |
|
| 139 | AAC ATG GTG GGC CAA AGG AT | NM_001190422.1 | 55 |
|
| 220 | GGT GGA GGC CAC ATC AAT CA | NM_214127.2 | 55 |
|
| 139 | CTT GCC AGT CGT GGT CAT CT | NM_001044580.1 | 57 |
|
| 119 | TAT ACG ACA GTT ACG ACG AC | NM_001159607.1 | 54 |
|
| 115 | ATA GCC TTC CAC CTT ACG CTC | XM_021085483.1 | 58 |
|
| 130 | AGT TTT CTG AGG CCC GTG AG | NM_001044544.1 | 58 |
Tan: annealing temperature (°C).